supp.fit

Olive Leaf Extract

13 benefits mapped to clinical evidence across supplements.

Dose per serving from products

683 products in our catalogue print how much Olive Leaf Extract a serving holds.

Most common: 100 mg to 250 mg, 22% of 683 products.

Dose per servingProducts
10 mg or less
34
10 mg to 25 mg
65
25 mg to 50 mg
77
50 mg to 100 mg
145
100 mg to 250 mg
153
250 mg to 500 mg
144
500 mg to 1 g
60
over 1 g
5

Dose per serving from research

7 study groups in 6 studies say how much Olive Leaf Extract participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 500 mg to 1 g, 43% of 7 study groups.

Daily doseStudy groups
100 mg to 250 mg
2
250 mg to 500 mg
1
500 mg to 1 g
3
1 g to 2.5 g
0
2.5 g to 5 g
0
5 g to 10 g
0
10 g to 25 g
1

See every study group

Benefit Evidence

Inflammation
Moderate

IL-6/IL-8/TNF-α ↓

CRP/IL-8 ↓

882 people

BP ↓ 3-6 mmHg

Stiffness/IL-8 ↓

681 people

SBP/DBP ↓ ~6-13

Metabolic markers ↓

681 people

LDL -0.19 mmol/L

Total cholesterol -0.32 mmol/L

681 people

Lower BP, TG

Less stiffness, IL-8

681 people

Insulin sensitivity +15%

Glucose, insulin AUC ↓

666 people

Better oxygen, less inflammation

+1.8%, -15.7 mg/L

203 people

Inflammation ↓; IL-6/8/TNF-α

Immune illness ↓; 28%

201 people

Faster healing, less pain

Faster healing, pain unchanged

106 people

Faster herpes healing -0.8d

Less pain, itching

106 people

Faster healing, -0.8 days

Less pain, itching

106 people

Oxygenation +1.8%

Inflammation -15.7 mg/L

Stay -1.7 days

141 people

Pain -1.19

Function -0.89

100 people

Research sources

Inflammation (4)
  1. Effects of Olive Leaf Extract on Metabolic Response, Liver and Kidney Functions and Inflammatory Biomarkers in Hypertensive Patients

    PubMed ID: 31930845

    Randomized trial in hypertensive patients showed significant decreases in IL‑6, IL‑8 and TNF‑α over 12 weeks—strong anti‑inflammatory evidence.

  2. Impact of phenolic-rich olive leaf extract on blood pressure, plasma lipids and inflammatory markers: a randomised controlled trial

    PubMed ID: 26951205

    Reduced plasma IL‑8 and modest improvements in BP and lipids in pre‑hypertensive men support inflammation modulation.

  3. Efficacy of olive leaves extract on the outcomes of hospitalized covid-19 patients: A randomized, triple-blinded clinical trial

    PubMed ID: 36319585

    OLE reduced CRP/ESR in hospitalized COVID patients alongside clinical improvement—robust anti‑inflammatory signal.

  4. Efficacy of olive leaf extracts in controlling blood pressure in hypertensive patients: a double-blind randomized clinical trial

    PubMed ID: 40990594

    Large trial showed improvements in inflammatory markers (CRP) along with BP and metabolic benefits—consistent anti‑inflammatory activity.

Blood circulation (2)
  1. Efficacy of olive leaf extracts in controlling blood pressure in hypertensive patients: a double-blind randomized clinical trial

    PubMed ID: 40990594

    Large RCT reduced 24‑h SBP, BP load and diastolic BP variability—strong evidence of improved vascular/circulatory function.

  2. Impact of phenolic-rich olive leaf extract on blood pressure, plasma lipids and inflammatory markers: a randomised controlled trial

    PubMed ID: 26951205

    Pre‑hypertensive crossover trial modestly lowered ambulatory BP and LDL—supports circulation/vascular benefit.

Blood pressure (2)
  1. Efficacy of olive leaf extracts in controlling blood pressure in hypertensive patients: a double-blind randomized clinical trial

    PubMed ID: 40990594

    Large multicenter RCT showed clinically meaningful 24‑h SBP reduction (~6.4 mmHg), lower BP load and BP variability—strong evidence.

  2. Impact of phenolic-rich olive leaf extract on blood pressure, plasma lipids and inflammatory markers: a randomised controlled trial

    PubMed ID: 26951205

    Pre‑hypertensive men had modest ambulatory BP reductions over 6 weeks—supportive of BP‑lowering effect.

Cholesterol (2)
  1. Impact of phenolic-rich olive leaf extract on blood pressure, plasma lipids and inflammatory markers: a randomised controlled trial

    PubMed ID: 26951205

    Modest reductions in total cholesterol and LDL in pre‑hypertensive men after 6 weeks—supports cholesterol‑lowering potential.

  2. Efficacy of olive leaf extracts in controlling blood pressure in hypertensive patients: a double-blind randomized clinical trial

    PubMed ID: 40990594

    Large RCT reported improvements in metabolic markers including triglycerides and some lipid measures—supports lipid benefit.

Heart health (2)
  1. Efficacy of olive leaf extracts in controlling blood pressure in hypertensive patients: a double-blind randomized clinical trial

    PubMed ID: 40990594

    Large RCT showed meaningful 24‑h SBP reduction, lower BP load/variability and improvements in metabolic/inflammatory markers—strong CV support.

  2. Impact of phenolic-rich olive leaf extract on blood pressure, plasma lipids and inflammatory markers: a randomised controlled trial

    PubMed ID: 26951205

    Pre‑hypertensive men had modest BP and LDL reductions and lower IL‑8—favourable cardiovascular profile.

Blood sugar (2)
  1. Olive (Olea europaea L.) leaf polyphenols improve insulin sensitivity in middle-aged overweight men: a randomized, placebo-controlled, crossover trial

    PubMed ID: 23516412

    12‑week RCT in overweight men showed improved insulin sensitivity, lower post‑meal glucose AUC and insulin AUC—strong glucose‑metabolic benefit.

  2. Efficacy of olive leaf extracts in controlling blood pressure in hypertensive patients: a double-blind randomized clinical trial

    PubMed ID: 40990594

    Large hypertensive trial reported improvements in glucose and metabolic markers along with BP—supports systemic glycaemic benefit.

Wellbeing (2)
  1. Efficacy of olive leaves extract on the outcomes of hospitalized covid-19 patients: A randomized, triple-blinded clinical trial

    PubMed ID: 36319585

    Improved clinical outcomes, inflammatory markers and shorter hospitalization in COVID patients indicate broad wellness benefit.

  2. Olive Leaf Extract Supplementation Improves Postmenopausal Symptoms: A Randomized, Double-Blind, Placebo-Controlled Parallel Study on Postmenopausal Women

    PubMed ID: 39599665

    Better menopausal QoL and some metabolic/bone signals suggest an overall wellness effect in that population.

Immune support (2)
  1. Effects of Olive Leaf Extract on Metabolic Response, Liver and Kidney Functions and Inflammatory Biomarkers in Hypertensive Patients

    PubMed ID: 31930845

    Reduced pro‑inflammatory cytokines (IL‑6, IL‑8, TNF‑α) in hypertensive patients, implying immune‑modulatory effects.

  2. Efficacy of olive leaves extract on the outcomes of hospitalized covid-19 patients: A randomized, triple-blinded clinical trial

    PubMed ID: 36319585

    Large RCT in COVID patients showed faster recovery, higher O2 sat and lower CRP/ESR—supports immune/host-response benefit.

Antimicrobial (2)
  1. The efficacy of olive leaf extract on healing herpes simplex virus labialis: A randomized double-blind study

    PubMed ID: 33541815

    Topical OLE outperformed 5% acyclovir for HSV‑1 lesion healing—evidence of antiviral/antimicrobial topical activity.

  2. Evaluating the effectiveness of topical olive leaf extract emulgel in managing recurrent herpes labialis: a randomized controlled clinical study

    PubMed ID: 39623211

    Topical OLE shortened healing time of herpes labialis vs acyclovir—supports antiviral topical activity.

Oral health (2)
  1. Evaluating the effectiveness of topical olive leaf extract emulgel in managing recurrent herpes labialis: a randomized controlled clinical study

    PubMed ID: 39623211

    Emulgel OLE accelerated herpes labialis healing vs acyclovir—supports oral/mucosal benefit.

  2. The efficacy of olive leaf extract on healing herpes simplex virus labialis: A randomized double-blind study

    PubMed ID: 33541815

    Topical OLE shortened HSV‑1 lesion healing and reduced symptoms on the lip (oral mucosa) compared with acyclovir.

Skin health (2)
  1. The efficacy of olive leaf extract on healing herpes simplex virus labialis: A randomized double-blind study

    PubMed ID: 33541815

    Topical 2% OLE healed HSV‑1 lesions faster and reduced pain/itching vs 5% acyclovir—clear topical/skin benefit.

  2. Evaluating the effectiveness of topical olive leaf extract emulgel in managing recurrent herpes labialis: a randomized controlled clinical study

    PubMed ID: 39623211

    Topical OLE emulgel shortened recurrent herpes labialis healing time vs acyclovir (~0.8 day faster)—positive skin/mucosal outcome.

Respiratory comfort (1)
  1. Efficacy of olive leaves extract on the outcomes of hospitalized covid-19 patients: A randomized, triple-blinded clinical trial

    PubMed ID: 36319585

    In hospitalized COVID patients OLE increased oxygen saturation and shortened hospitalization—supports respiratory/clinical benefit.

Joint comfort (1)
  1. Impact of olive leaf extract on pain management and functional improvement in elderly patients with knee osteoarthritis: A randomized controlled trial

    PubMed ID: 39955806

    RCT in elderly knee OA patients showed reduced pain and improved function with oral and/or topical OLE.

Similar by evidence

Supplements the same benefits carry qualifying findings for — a fact about the evidence graph, not a recommendation to swap.

Products with Olive Leaf Extract

Search all

1440 products whose verified label declares Olive Leaf Extract — not every bottle that mentions it in a title.

Being studied right now

Recruiting clinical trials registered on ClinicalTrials.gov. A trial in progress has no result yet — this is what the field is asking, not what it found.